… PD-L1 expression is associated with survival and predicts response to PD-1 or PD-L1 …
the frequency and prognostic significance of PD-L1 expression in salivary duct carcinoma. …

… PD-L1 may play a key role in the biology of Xp11.2 translocation RCC and collecting duct
carcinoma … .2 translocation RCC and collecting duct carcinomas, even evaluating a large cohort…

Aims Salivary duct carcinoma (SDC) is an aggressive salivary malignancy that results in
high mortality rates and is often resistant to chemotherapy. Anti‐programmed death‐1 (PD‐1)/…

… seen for PD-L1 expression in TIICs (p = 0.058). Patients with salivary duct carcinomas and
PD-L1 … with both tumor cells and TIIC expressing PD-L1 a significantly worse DFS (p = 0.030). …

… collecting duct carcinoma (CDC) that responded to nivolumab, a programmed death 1 (PD‑1…
PD‑L1 was highly expressed in both primary tumor and the metastatic regions. Therapy with …

… Salivary duct carcinoma (SDC) is an aggressive malignancy that accounts for 1%–3% of …
carcinomas (SGC). The disease is morphologically similar to invasive ductal breast carcinoma …

… , and undifferentiated carcinoma. We describe an extremely rare case of salivary duct carcinoma
… Herein, we describe a case of salivary duct carcinoma arising in a WT and concurrent …

Salivary duct carcinoma (SDC) commonly expresses androgen receptor (AR) and HER2,
giving rise to treatment implications. SDC may also express programmed-death-ligand-1 (PD-…

… Although there have been some reports on the association between salivary gland carcinoma
and PD-L1 or PD-L2, to the best of our knowledge, a few reports on PD-L1/PD-L2 in SDC …

… multiple approaches of treatments for salivary duct carcinoma, there has been a need for …
the frequency of PD-L1 expression and its impact on survival rate in salivary duct carcinoma. …